SOSV

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.

SunGreenH2 is a company focused on producing high-performance electrolysers for green hydrogen generation using advanced materials and nanotechnology. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables on-site hydrogen production at a low cost. By utilizing sunlight and water, SunGreenH2's patented technology facilitates the production of zero-emissions hydrogen, supporting sustainable practices across various industries, including transport, buildings, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to enable widespread adoption of green hydrogen, contributing to a more sustainable energy landscape.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Kutanios is a London-based biotechnology company specialising in the development of biodegradable molecules for skincare products. Their focus lies in creating innovative compounds for anti-ageing, sun protection, and over-the-counter anti-acne treatments. The company's unique selling proposition is its science-based approach, utilising green technology to manufacture molecules with a novel mechanism of action that sequesters lipid peroxides caused by sunlight, atmospheric pollution, and tobacco smoke. This enables their products to effectively prevent ageing, sunburn, and skin cancers.

Kutanios is a London-based biotechnology company specialising in the development of biodegradable molecules for skincare products. Their focus lies in creating innovative compounds for anti-ageing, sun protection, and over-the-counter anti-acne treatments. The company's unique selling proposition is its science-based approach, utilising green technology to manufacture molecules with a novel mechanism of action that sequesters lipid peroxides caused by sunlight, atmospheric pollution, and tobacco smoke. This enables their products to effectively prevent ageing, sunburn, and skin cancers.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Sava is a company focused on revolutionizing health interactions through advanced biosensing technology. Their innovative solutions aim to access bodily information painlessly, in real-time, and at an affordable cost. Sava's technology is particularly beneficial for athletes, as it provides instant feedback about the body's molecular signature, enabling continuous monitoring of glucose and lactate levels. This data helps athletes train more effectively, predict exhaustion, and optimize dietary plans.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

SunGreenH2 is a company focused on producing high-performance electrolysers for green hydrogen generation using advanced materials and nanotechnology. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables on-site hydrogen production at a low cost. By utilizing sunlight and water, SunGreenH2's patented technology facilitates the production of zero-emissions hydrogen, supporting sustainable practices across various industries, including transport, buildings, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to enable widespread adoption of green hydrogen, contributing to a more sustainable energy landscape.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Arthronica Ltd is a technology company based in London, United Kingdom, focused on developing an artificial intelligence-based platform for patient monitoring and rehabilitation, specifically targeting chronic rheumatic conditions such as arthritis. Founded in 2018, Arthronica's solutions incorporate advanced features such as skeletal tracking, visual strength assessment, image analysis, and video analysis. The company aims to provide medical practitioners with tools to accurately monitor and predict disease activities, thereby enhancing patient care and treatment outcomes. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, and it has participated in the Entrepreneur First program, which supports the growth of technology startups.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Arthronica Ltd is a technology company based in London, United Kingdom, focused on developing an artificial intelligence-based platform for patient monitoring and rehabilitation, specifically targeting chronic rheumatic conditions such as arthritis. Founded in 2018, Arthronica's solutions incorporate advanced features such as skeletal tracking, visual strength assessment, image analysis, and video analysis. The company aims to provide medical practitioners with tools to accurately monitor and predict disease activities, thereby enhancing patient care and treatment outcomes. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, and it has participated in the Entrepreneur First program, which supports the growth of technology startups.

Caura Ltd. is a London-based company that specializes in designing and manufacturing innovative vehicle management solutions. The company's platform facilitates payments for essential car-related expenses, including parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Caura Protect, an FCA-registered product, enables drivers to purchase and manage motor insurance from multiple insurers. Additionally, Caura Maintain streamlines the management of MOTs and vehicle servicing. Founded in 2018, Caura aims to simplify car ownership by integrating various services into an accessible platform, enhancing the overall experience for drivers.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

NeuroCreate Ltd. is a London-based company established in 2017 that develops an artificial intelligence platform known as FlowCreate Innovator. This platform offers a range of digital tools designed to enhance user efficiency and productivity through improved cognitive processes. By leveraging neuroscience, NeuroCreate aims to help individuals achieve a mental state referred to as "Flow," which facilitates effortless problem-solving and creative thinking. The platform not only seeks to improve work performance but also focuses on enhancing mental well-being and reducing stress. NeuroCreate's vision centers around human-centered AI for Industry 5.0, where its innovative approach, termed 'NeuroDesign,' integrates the principles of neuroscience to create ethical digital products that support cognitive health and productivity in the workplace.

Caura Ltd. is a London-based company that specializes in designing and manufacturing innovative vehicle management solutions. The company's platform facilitates payments for essential car-related expenses, including parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Caura Protect, an FCA-registered product, enables drivers to purchase and manage motor insurance from multiple insurers. Additionally, Caura Maintain streamlines the management of MOTs and vehicle servicing. Founded in 2018, Caura aims to simplify car ownership by integrating various services into an accessible platform, enhancing the overall experience for drivers.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Encelo Laboratories Limited is a biotechnology company based in London, United Kingdom, specializing in the development of innovative cell isolation tools. Founded in 2017, the company focuses on providing researchers in academia and industry with non-invasive, on-demand, and remote access to individual human cells. Its flagship product, the Cell Isolation Cup, enables the selective isolation and preservation of live cells from urine, facilitating their shipment for further research. Encelo's offerings cater to a diverse clientele, including pharmaceutical companies, academic researchers, biobanks, and clinicians. The company's mission is to enhance personalized medicine by allowing universal access to stem cells, thereby supporting advancements in stem cell research, cell separation, and cell sequencing. Through these efforts, Encelo aims to make personalized treatments more accessible and cost-effective, particularly for patients with rare diseases and children.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Zartis is a technology consulting firm that specializes in providing tailored software development services. With a strong emphasis on nearshore outsourcing, the company mitigates risks associated with outsourcing by leveraging its deep technical expertise and industry knowledge. Zartis operates engineering hubs in Ireland, Spain, and Poland, where a diverse team of professionals from nineteen nationalities collaborates to deliver innovative solutions across various sectors, including e-commerce, financial services, medtech, and renewable energy. Their service offerings encompass website development, technology consulting, team augmentation, and product development, enabling clients to enhance their technological capabilities while reducing agency costs. Zartis's engineers are proficient in a wide range of programming languages and cloud architectures, ensuring comprehensive management of the entire delivery process to facilitate successful project outcomes.